期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

EUK4010对Presenilin-1/Presenilin-2双基因敲除小鼠神经退行性病变的影响 被引量：2

Effects of EUK4010 on Neurodegenerative Symptoms in Presenilin-1/Presenilin-2 Double Knockout Mice
原文传递
导出
摘要 为了研究本实验室筛选出的单体化合物EUK4010对Presenilin-1/Presenilin-2双基因敲除小鼠神经退行性症状的作用及机制,将EUK4010(10μg/g体重)分别作用于2月龄和6月龄的双基因敲除小鼠(dKO小鼠),通过组织学、实时荧光定量PCR及Western blot、行为学等方法发现该化合物对dKO小鼠的体重下降、脑室扩大、海马萎缩等有一定缓解作用,但对dKO小鼠认知行为的改变尚不明显.进一步分析发现,EUK4010对dKO小鼠神经退行性症状的改善可能是抑制了由Presenilin-1/Presenilin-2双基因敲除导致的GFAP、C1qα与C4等炎症反应相关基因在皮层与海马中的表达上调所致. To investigate the effects of EUK4010 on the neurodegenerative phenotypes of Presenilin-1/Presenilin-2 double knockout mice,10μg/g of body weight of EUK4010 was administrated on Presenilin-1/Presenilin-2 double knockout mice at 2-7 months and 6-11 months,respectively.Through the tests of morphology,Real-time PCR and behavior,it is found that the neurodegenerative symptoms of loss of body weight,enlargement of ventricles and atrophy of hippocampus were ameliorated by EUK4010,whereas the cognitive behaviors were not significantly influenced by EUK4010.Further investigations indicated that the ameliorations of the neurodegenerative symptoms by EUK4010 could depend on down-regulating the up-regulation of inflammatory response mediators such as GFAP,C1qα and C4 gene in dKO cortex and hippocampus induced by Presenilin-1/Presenilin-2 double knockout.
作者 陈逸群 姜旭 张冬丽 王丽丽 梅兵
机构地区 华东师范大学脑功能基因组学研究所
出处 《复旦学报（自然科学版）》 CAS CSCD 北大核心 2009年第5期648-655,共8页 Journal of Fudan University：Natural Science
基金 上海市科学技术委员会"登山行动计划"资助项目(06DZ19003)
关键词 PRESENILIN 双基因敲除小鼠 神经退行性病变 EUK4010 炎症反应因子 Presenilin double knockout mice neurodegenerative symptoms EUK4010 inflammatory response mediators
分类号 R964 [医药卫生—药理学]
  • 相关文献

参考文献15

  • 1Blennow K, De Leon M J, Zetterberg H. Alzheimer's disease[J]. Lancet, 2006,368(9533): 387 -403.
  • 2Newman M, Musgrave F I, Lardelli M. Alzheimer disease:Amyloidogenesis, the presenilins and animal models[J]. Biochim Biophys Acta, 2007,1772(3) : 285- 297.
  • 3Lambert J C, Amouyel P. Genetic heterogeneity of Alzheimer's disease: Complexity and advances[J]. Psychoneuroendocrinology, 2007,32(1) ; S62-S70.
  • 4Marjaux E, Hartmann D, De Strooper B. Presenilins in memory, Alzheimer's disease, and therapy[J]. Neuron, 2004,42(2): 189-192.
  • 5Selkoe D J, Wolfe M S. Presenilin: Running with scissors in the membrane[J].Cell, 2007,131(2) : 215- 221.
  • 6Shen J, Bronson R T, Chen D F, et al. Skeletal and CNS defects in Presenilin-1-deficient mice[J]. Cell, 1997,89(4) : 629-639.
  • 7De Strooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein[J]. Nature, 1998,391(6665) : 387-390.
  • 8Herreman A, Hartmann D, Annaert Wet al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency[J]. Proc Natl Acad Sci, 1999,96(21): 111872-111877.
  • 9Feng R B, Rampon C, Tang Y P, et al. Deficient neurogenesis in forebrain-specific Presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces [J]. Neuron, 2001,32 (5): 911-926.
  • 10Yu H K, Saura C A, Choi S Y, et al. APP processing and synaptic plasticity in Presenilin-1 conditional knockout mice[J]. Neuron, 2001,31(5) : 713-726.

同被引文献29

  • 1Blennow K. de Leon M J. Zetterberg H. Alzheimer's disease[J]. Lancet. 2006. 368(9533): 387-403.
  • 2Goedert M. Spillantini M G. A century of Alzheimer's disease[J]. Science. 2006. 314(5800): 777-780.
  • 3Nikolaos K. Robakis. Mechanisms of AD neurodegeneration may be independent of A β and its derivatives [J]. Neurobiol Aging. 2011. 32(3): 372-379.
  • 4Czech C. Tremp G. Pradier L. Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms[J]. Prog Neurobiol , 2000. 60(4): 363-384.
  • 5Haass C. Presenilins , Genes for life and death[J]. Neuron. 1997. 18(5): 687-690.
  • 6Suh Y H. Checler F. Amyloid precursor protein. presenilins , and alpha-synuclein, Molecular pathogenesis and pharrna-cological applications in Alzheimer's disease[J]. Pharmacal Rev. 2002. 54(3): 469-525.
  • 7Selkoe D J. Wolfe M S. Presenilin . Running with scissors in the membrane[J]. Cell. 2007. 131 (2): 215-221.
  • 8Shen J. Bronson R T. Chen D F. et al. Skeletal and ens defects in presenilin-1-deficient mice[J]. Cell. 1997. 89(4): 629-639.
  • 9Steiner H. Duff K. Capell A. et al. A loss of function mutation of presenilin2 interferes with amyloid beta-peptide production and notch signaling[J]. J Biol Chern. 1999.274(40): 28669-28673.
  • 10Feng R B. Wang H M. Wang J L, et al. Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2[J]. Proc Natl Acad Sci. 2004. 101(21): 8162-8167.

引证文献2

二级引证文献6

复旦学报（自然科学版）
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部